{"id":20725,"date":"2022-02-10T16:28:21","date_gmt":"2022-02-10T15:28:21","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=20725"},"modified":"2022-02-10T16:28:24","modified_gmt":"2022-02-10T15:28:24","slug":"berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/","title":{"rendered":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service"},"content":{"rendered":"\n

Article published on October 1rst, 2022 on Berkeley Lights website<\/a><\/p>\n\n\n\n

EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.<\/p>\n\n\n\n

In this partnership, Aanika will use Berkeley Lights’ high-throughput, functional screening service to rapidly identify and optimize functional, antimicrobial peptides (AMPs) capable of killing harmful bacteria, including those that cause outbreaks of foodborne illness. In addition, the Beacon\u00ae<\/sup> Optofluidic Platform will be leveraged to find peptides that are toxic to bacteria to create a new antibacterial tag that will then be applied to their bacterial spore-based barcoding technology to protect the food supply chain.

\u201cBerkeley Lights\u2019 high-throughput, functional screening service, based on our proprietary cell-free expression technology, is accelerating novel discoveries to develop solutions and products in the agricultural space,\u201d said Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights. \u201cSpecifically, applying the Berkeley Lights platform to AMPs allows us to rapidly map and identify the top mutational sites to further optimize AMP performance.\u201d<\/p>\n\n\n\n

AMPs are gaining popularity as antibacterial agents across a wide range of applications, particularly as microbes are becoming more resistant to antibiotics, and are a growing focus for both companies.<\/p>\n\n\n\n

\u201cTracking, tracing and identifying the origin of food borne illnesses is just the beginning of what Aanika\u2019s \u2018watermark\u2019 technology can do to help improve and protect our global food system,\u201d said Aanika co-founder and CEO Vishaal Bhuyan. \u201cThe partnership with Berkley Lights will enable us to move faster, and go deeper, into uncovering and unlocking the opportunities to have greater economic, environmental and human health impact.\u201d<\/p>\n\n\n\n

Berkeley Lights will participate in the downstream economics created by its enabling technology through a royalty arrangement as part of this strategic partnership. Additional terms of the agreement are not disclosed. This is Berkeley Lights\u2019 second announced high-throughput, functional screening partnership following the Bayer Partnership<\/a> announced in 2021.<\/p>\n\n\n\n

About Berkeley Lights<\/strong><\/p>\n\n\n\n

Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. <\/p>\n\n\n\n

Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect\u2122 chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.<\/p>\n\n\n\n

Berkeley Lights\u2019 Beacon\u00ae<\/sup> and Lightning\u2122<\/sup> systems and Culture Station\u2122<\/sup> instrument are FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.<\/strong><\/p>\n\n\n\n

About Aanika Biosciences<\/strong><\/p>\n\n\n\n

Aanika Biosciences was co-founded in 2018 by Vishaal Bhuyan after he personally experienced the consequences of ordering fresh seeds and receiving stale, contaminated products instead. He made it is his mission to create a safer food supply by finding a way to track, trace and authenticate products. Aanika\u2019s customized microbial-based tags help companies gain valuable insights about their supply chains, help their customers make better consumption choices, and create a more sustainable world.<\/p>\n\n\n\n

Forward-Looking Statements<\/strong><\/p>\n\n\n\n

To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. <\/p>\n\n\n\n

Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company\u2019s growth and continual evolution see the statements in the “Risk Factors” sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.<\/p>\n\n\n\n

Media Contacts<\/strong>
Media @berkeleylights.com<\/a>
Laura.shulman@foodfuturestrategies.com<\/a>

Investor Contact<\/strong>
IR@berkeleylights.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Article published on October 1rst, 2022 on Berkeley Lights website EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of […]<\/p>\n","protected":false},"author":139,"featured_media":20729,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"\nBerkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-10T15:28:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-10T15:28:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"473\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service\",\"datePublished\":\"2022-02-10T15:28:21+00:00\",\"dateModified\":\"2022-02-10T15:28:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\"},\"wordCount\":738,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\",\"name\":\"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg\",\"datePublished\":\"2022-02-10T15:28:21+00:00\",\"dateModified\":\"2022-02-10T15:28:24+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg\",\"width\":473,\"height\":330,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/","og_locale":"fr_FR","og_type":"article","og_title":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2022-02-10T15:28:21+00:00","article_modified_time":"2022-02-10T15:28:24+00:00","og_image":[{"width":473,"height":330,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service","datePublished":"2022-02-10T15:28:21+00:00","dateModified":"2022-02-10T15:28:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/"},"wordCount":738,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/","name":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg","datePublished":"2022-02-10T15:28:21+00:00","dateModified":"2022-02-10T15:28:24+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/02\/E-coli.jpg","width":473,"height":330,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-21 20:48:34","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/20725"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=20725"}],"version-history":[{"count":2,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/20725\/revisions"}],"predecessor-version":[{"id":20733,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/20725\/revisions\/20733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/20729"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=20725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=20725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=20725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}